Detalhe da pesquisa
1.
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.
Proc Natl Acad Sci U S A
; 111(12): 4596-601, 2014 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24623853
2.
The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults.
Alzheimers Dement
; 10(3): 319-27, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23871264
3.
Clinical research risk assessment among individuals with mild cognitive impairment.
Am J Geriatr Psychiatry
; 20(10): 878-86, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22549368
4.
Medical student education program in Alzheimer's disease: the PAIRS Program.
BMC Med Educ
; 12: 80, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22906234
5.
Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome.
Ann Clin Transl Neurol
; 5(3): 323-332, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29560377
6.
Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales.
J Neurodev Disord
; 7(1): 30, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26379794